Wake-up stroke, defined as the situation where a patient awakens with stroke symptoms that were not present prior to falling asleep, represents roughly 1 in 5 acute ischemic strokes and remains a therapeutic dilemma. Patients with wake-up stroke were excluded from most ischemic stroke treatment trials and are often not eligible for acute reperfusion therapy in clinical practice, leading to poor outcomes. Studies of neuroimaging with standard noncontrast computed tomography (CT), magnetic resonance imaging (MRI), and multimodal perfusion-based CT and MRI suggest wake-up stroke may occur shortly before awakening and may assist in selecting patients for acute reperfusion therapies. Pilot studies of wake-up stroke treatment based on these neuroimaging features are promising but have limited generalizability. Ongoing randomized treatment trials using neuroimaging-based patient selection may identify a subset of patients with wake-up stroke that can safely benefit from acute reperfusion therapies.
SaverJL. Time is brain—quantified. Stroke J Cereb Circ. 2006;37
(1):263–266.
2.
MeretojaAKeshtkaranMSaverJLStroke thrombolysis: save a minute, save a day. Stroke J Cereb Circ. 2014;45
(4):1053–1058.
3.
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333
(24):1581–1588.
4.
AlbersGWClarkWMMaddenKPHamiltonSADavisSMDonnanGA. ATLANTIS trial: results for patients treated within 3 hours of stroke onset * editorial comment: results for patients treated within 3 hours of stroke onset. Stroke. 2002;33
(2):493–496.
5.
HackeWKasteMBluhmkiEThrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359
(13):1317–1329.
6.
HackeWDonnanGFieschiCAssociation of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363
(9411):768–774.
7.
SaverJLFonarowGCSmithEETime to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA J Am Med Assoc. 2013;309
(23):2480–2488.
8.
California Acute Stroke Pilot Registry (CASPR) Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology. 2005;64
(4):654–659.
9.
MichelPOdierCRutgersMThe Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke J Cereb Circ. 2010;41
(11):2491–2498.
MarlerJRPriceTRClarkGLMorning increase in onset of ischemic stroke. Stroke J Cereb Circ. 1989;20
(4):473–476.
12.
RicciSCelaniMGVitaliRLa RosaFRighettiEDucaE. Diurnal and seasonal variations in the occurrence of stroke: a community-based study. Neuroepidemiology. 1992;11
(2):59–64.
13.
LagoAGeffnerDTemblJLandeteLValeroCBaqueroM. Circadian variation in acute ischemic stroke: a hospital-based study. Stroke J Cereb Circ. 1998;29
(9):1873–1875.
14.
BornsteinNMGurAYFainshteinPKorczynAD. Stroke during sleep: epidemiological and clinical features. Cerebrovasc Dis Basel Switz. 1999;9
(6):320–322.
SerenaJDávalosASeguraTMostaceroECastilloJ. Stroke on awakening: looking for a more rational management. Cerebrovasc Dis Basel Switz. 2003;16
(2):128–133.
17.
NadeauJOFangJKapralMKSilverFLHillMD; Registry of the Canadian stroke network. Outcome after stroke upon awakening. Can J Neurol Sci J Can Sci Neurol. 2005;32
(2):232–236.
18.
BoodeBWelzenVFrankeCvan OostenbruggeR. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided. Cerebrovasc Dis Basel Switz. 2007;23
(4):294–298.
19.
Jiménez-CondeJOisARodríguez-CampelloAGomisMRoquerJ. Does sleep protect against ischemic stroke? Less frequent ischemic strokes but more severe ones. J Neurol. 2007;254
(6):782–788.
TurinTCKitaYRumanaNWake-up stroke: incidence, risk factors and outcome of acute stroke during sleep in a Japanese population. Takashima Stroke Registry. 1988-2003. Eur Neurol. 2013;69
(6):354–359.
22.
FinkJNKumarSHorkanCThe stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke J Cereb Circ. 2002;33
(4):988–993.
23.
MoradiyaYJanjuaN. Presentation and outcomes of “wake-up strokes” in a large randomized stroke trial: analysis of data from the international stroke trial. J Stroke Cerebrovasc Dis. 2013;22
(8):e286–e292.
24.
KotonSTanneDBornsteinNM; NASIS Investigators. Ischemic stroke on awakening: patients’ characteristics, outcomes and potential for reperfusion therapy. Neuroepidemiology. 2012;39
(3-4):149–153.
25.
TodoKMoriwakiHSaitoKTanakaMOeHNaritomiH. Early CT findings in unknown-onset and wake-up strokes. Cerebrovasc Dis Basel Switz. 2006;21
(5-6):367–371.
26.
HuisaBNRamanRErnstromKAlberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc. 2010;19
(6):475–479.
27.
MackeyJKleindorferDSucharewHPopulation-based study of wake-up strokes. Neurology. 2011;76
(19):1662–1667.
28.
RoveriLLa GioiaSGhidinelliCAnzaloneNDe FilippisCComiG. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke. J Stroke Cerebrovasc Dis. 2013;22
(6):703–708.
29.
ManawaduDBodlaSKeepJJaroszJKalraL. An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Stroke. 2013;44
(2):427–431.
30.
CohenMCRohtlaKMLaveryCEMullerJEMittlemanMA. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol. 1997;79
(11):1512–1516.
31.
ElliottWJ. Circadian Variation in the timing of stroke onset: a meta-analysis. Stroke. 1998;29
(5):992–996.
32.
PizzaFBiallasMKallweitUWolfMBassettiCL. Cerebral hemodynamic changes in stroke during sleep-disordered breathing. Stroke J Cereb Circ. 2012;43
(7):1951–1953.
33.
OzdemirOBeletskyVHachinskiVSpenceJD. Cerebrovascular events on awakening, patent foramen ovale and obstructive sleep apnea syndrome. J Neurol Sci. 2008;268
(1-2):193–194.
34.
CicconeAProserpioPRoccatagliataDVWake-up stroke and TIA due to paradoxical embolism during long obstructive sleep apnoeas: a cross-sectional study. Thorax. 2013;68
(1):97–104.
35.
SomersVKDykenMEMarkALAbboudFM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328
(5):303–307.
36.
RedonJ. The normal circadian pattern of blood pressure: implications for treatment. Int J Clin Pract Suppl. 2004;(145):3–8.
37.
MusumeciVRosaSCarusoAZuppiCZappacostaBTutinelliF. Abnormal diurnal changes in in-vivo platelet activation in patients with atherosclerotic diseases. Atherosclerosis. 1986;60
(3):231–236.
38.
AndrewsNPGralnickHRMerrymanPVailMQuyyumiAA. Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry study. J Am Coll Cardiol. 1996;28
(7):1789–1795.
39.
KozinskiMBielisLWisniewska-SzmytJDiurnal variation in platelet inhibition by clopidogrel. Platelets. 2011;22
(8):579–587.
40.
OttoME. Early morning attenuation of endothelial function in healthy humans. Circulation. 2004;109
(21):2507–2510.
41.
EhrlyAMJungG. Circadian rhythm of human blood viscosity. Biorheology. 1973;10
(4):577–583.
42.
SoulbanGLabrecqueG. Circadian rhythms of blood clotting time and coagulation factors II, VII, IX and X in rats. Life Sci. 1989;45
(25):2485–2489.
43.
AndreottiFDaviesGJHackettDRMajor circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol. 1988;62
(9):635–257.
44.
BremnerWFSothernRBKanabrockiELRelation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J. 2000;139
(1):164–173.
45.
BlackHRElliottWJGranditsGPrincipal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA. 2003;289
(16):2073–2082.
46.
DeguchiYAminoMAdachiKCircadian distribution of paroxysmal atrial fibrillation in patients with and without structural heart disease in untreated state. Ann Noninvasive Electrocardiol. 2009;14
(3):280–289.
47.
RiccioPMKleinFRPagani CassaraFNewly diagnosed atrial fibrillation linked to wake-up stroke and TIA: hypothetical implications. Neurology. 2013;80
(20):1834–1840.
48.
NakanoSIsedaTKawanoHYoneyamaTIkedaTWakisakaS. Correlation of early CT signs in the deep middle cerebral artery territories with angiographically confirmed site of arterial occlusion. AJNR Am J Neuroradiol. 2001;22
(4):654–659.
49.
MoseleyMEKucharczykJMintorovitchJDiffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol. 1990;11
(3):423–429.
50.
VenkatesanRLinWGurleyikKAbsolute measurements of water content using magnetic resonance imaging: preliminary findings in an in vivo focal ischemic rat model. Magn Reson Med. 2000;43
(1):146–150.
51.
ThomallaGRossbachPRosenkranzMNegative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol. 2009;65
(6):724–732.
52.
HuisaBNLiebeskindDSRamanRDiffusion-weighted imaging-fluid attenuated inversion recovery mismatch in nocturnal stroke patients with unknown time of onset. J Stroke Cerebrovasc Dis. 2013;22
(7):972–977.
53.
AokiJKimuraKIguchiYShibazakiKSakaiKIwanagaT. FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci. 2010;293
(1-2):39–44.
54.
EbingerMGalinovicIRozanskiMBruneckerPEndresMFiebachJB. Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock?Stroke. 2010;41
(2):250–255.
55.
PetkovaMRodrigoSLamyCMR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology. 2010;257
(3):782–92.
56.
EmeriauSSerreIToubasOPombourcqFOppenheimCPierotL. Can diffusion-weighted imaging-fluid-attenuated inversion recovery mismatch (positive diffusion-weighted imaging/negative fluid-attenuated inversion recovery) at 3 tesla identify patients with stroke at <4.5 hours?Stroke. 2013;44
(6):1647–1651.
57.
ThomallaGChengBEbingerMDWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4.5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol. 2011;10
(11):978–986.
58.
KimBJKimY-HKimY-JColor-coded fluid-attenuated inversion recovery images improve inter-rater reliability of fluid-attenuated inversion recovery signal changes within acute diffusion-weighted image lesions. Stroke. 2014;45
(9):2801–2804.
59.
BarretoADMartin-SchildSHalleviHThrombolytic therapy for patients who wake-up with stroke. Stroke. 2009;40
(3):827–832.
60.
IosifCOppenheimCTrystramDDomigoVMederJ-F. MR Imaging-based decision in thrombolytic therapy for stroke on awakening: report of 2 cases. Am J Neuroradiol. 2008;29
(7):1314–1316.
61.
ChoA-HSohnS-IHanM-KSafety and efficacy of MRI-based thrombolysis in unclear-onset stroke. Cerebrovasc Dis. 2008;25
(6):572–579.
62.
BreuerLSchellingerPDHuttnerHBFeasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: initial single-centre experience. Int J Stroke. 2010;5
(2):68–73.
63.
KimJ-TParkM-SNamT-SThrombolysis as a factor associated with favorable outcomes in patients with unclear-onset stroke: thrombolysis in unclear-onset stroke. Eur J Neurol. 2011;18
(7):988–994.
64.
AokiJKimuraKIguchiYIntravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis. 2011;31
(5):435–441.
65.
EbingerMScheitzJFKufnerAEndresMFiebachJBNolteCH. MRI-based intravenous thrombolysis in stroke patients with unknown time of symptom onset: MRI-based thrombolysis in stroke of unknown onset. Eur J Neurol. 2012;19
(2):348–350.
66.
ManawaduDBodlaSJaroszJKeepJKalraL. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients. Stroke. 2013;44
(8):2226–2231.
67.
BaiQZhaoZFuPClinical outcomes of fast MRI-based thrombolysis in wake-up strokes compared to superacute ischemic strokes within 12 hours. Neurol Res. 2013;35
(5):492–497.
68.
NatarajanSKSnyderKVSiddiquiAHIonitaCCHopkinsLNLevyEI. Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes. Stroke. 2009;40
(10):3269–3274.
69.
StampflSRinglebPAHaehnelSRecanalization with stent-retriever devices in patients with wake-up stroke. Am J Neuroradiol. 2013;34
(5):1040–1043.
70.
JungSGrallaJFischerUSafety of endovascular treatment beyond the 6-h time window in 205 patients. Eur J Neurol. 2013;20
(6):865–871.
NatarajanSKKarmonYSnyderKVProspective acute ischemic stroke outcomes after endovascular therapy: a real-world experience. World Neurosurg. 2010;74
(4-5):455–464.
73.
ManawaduDBodlaSKeepJKalraL. Influence of age on thrombolysis outcome in wake-up stroke. Stroke. 2013;44
(10):2898–2900.
74.
BraccoSTassiRGennariPWake-up (or wake-up for) stroke: a treatable stroke. Neuroradiol J. 2013;26
(5):573–578.
75.
SungSLeeT. E-070 acute recanalization with stenting for wake-up stroke. J Neurointerv Surg. 2014;6
(suppl 1):A71–A71.
76.
KangD-WSohnS-IHongK-SReperfusion Therapy in Unclear-Onset Stroke Based on MRI Evaluation (RESTORE): a prospective multicenter study. Stroke. 2012;43
(12):3278–3283.
77.
HillMDKenneyCDzialowskiITissue Window in Stroke Thrombolysis study (TWIST): a safety study. Can J Neurol Sci J Can Sci Neurol. 2013;40
(1):17–20.
78.
AdamsHPEffronMBTornerJEmergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke J Cereb Circ. 2008;39
(1):87–99.
79.
AdamsHPLeiraECTornerJCTreating patients with “wake-up” stroke: the experience of the AbESTT-II trial. Stroke. 2008;39
(12):3277–3282.
80.
MichelPNtaiosGReichhartMPerfusion-CT guided intravenous thrombolysis in patients with unknown-onset stroke: a randomized, double-blind, placebo-controlled, pilot feasibility trial. Neuroradiology. 2012;54
(6):579–588.
81.
ThomallaGFiebachJBØstergaardLA multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP): protocols. Int J Stroke. 2014;9
(6):829–836.
82.
ThomallaGEbingerMFiehlerJFiebachJBEndresMGerloffC. EU-funded treatment study: WAKE-UP: a randomized, placebo-controlled MRI-based trial of thrombolysis in wake-up stroke [in German]. Nervenarzt. 2012;83
(10):1241–1251.
83.
KogaMToyodaKKimuraKTHrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) trial. Int J Stroke. 2014;9
(8):1117–1124.
84.
MaHParsonsMWChristensenSA multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke. 2012;7
(1):74–80.
85.
MR WITNESS: a study of intravenous thrombolysis with alteplase in MRI-selected patients [Internet]; 2014. Web site. http://www.clinicaltrials.gov/show/NCT01282242. Accessed October 9, 2014.
ChernyshevOYGaramiZCallejaSYield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke. 2005;36
(1):32–37.
91.
ChambersBRMeroryJRSmidtV. Doppler diagnosis in cases of acute stroke. Med J Aust. 1989;150
(7):382–384.
92.
CamerlingoMCastoLCensoriBFerraroBGazzanigaGCMamoliA. Transcranial Doppler in acute ischemic stroke of the middle cerebral artery territories. Acta Neurol Scand. 1993;88
(2):108–111.
93.
LeeDHGaoFQRankinRNPelzDMFoxAJ. Duplex and color Doppler flow sonography of occlusion and near occlusion of the carotid artery. AJNR Am J Neuroradiol. 1996;17
(7):1267–1274.
94.
AlexandrovAVDemchukAMWeinTHGrottaJC. Yield of transcranial Doppler in acute cerebral ischemia. Stroke J Cereb Circ. 1999;30
(8):1604–1609.
JauchECSaverJLAdamsHPGuidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44
(3):870–947.
